HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Prion Disease

Prion Disease

Prion Disease is a rare, progressive, and fatal neurodegenerative disorder caused by the accumulation of a misfolded prion protein in the brain. Prion diseases, also known as transmissible spongiform encephalopathies, affect both humans and animals. In humans, the most common forms are Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker Syndrome (GSS), familial fatal insomnia (FFI), and kuru. Prion diseases are caused by misfolded proteins that become detectable in the form of aggregates or amyloid deposits in the brain. Prion proteins are primarily composed of amino acids. These proteins, when present in a normal configuration, are essential for normal cell functions. However, in the presence of the misfolded form, the prion proteins cause an infection that leads to misfolding of the normal protein in cells, which is then passed between cells when they come into contact. The misfolded structure of the prion protein causes the cell to accumulate the abnormal protein and leads to neuronal death and other degenerative changes. Due to its infectious nature and the fact that the misfolded proteins are very resistant to degradation, prion diseases pose a significant public health threat. As the cause of prion diseases is still not fully understood, the treatment options tend to be limited to supportive care. The primary approach towards preventing the spread of prion diseases is to ensure that any contaminated food sources and medical equipment are properly disposed of, and that public health measures are in place to alert people to potential risks. Being diagnosed with prion diseases can be devastating, as the diseases typically have a rapid and fatal course. There currently is no cure, and at present, the prognosis tends to be grim. Research is ongoing in the area of prion diseases, with a focus on identifying potential treatments and possible ways to diagnose and monitor the progression of the disease in individuals.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros

Milton C R Medeiros

Irmandade Santa Casa de Arapongas PR, Brazil
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Sergei M Danilov

Sergei M Danilov

University of Illinois, United States

Submit your abstract Today

Watsapp